首页> 美国政府科技报告 >Novel Molecular Target for Breast Cancer Prevention and Treatment
【24h】

Novel Molecular Target for Breast Cancer Prevention and Treatment

机译:一种新的乳腺癌预防和治疗分子靶点

获取原文

摘要

We have investigated the mechanism by which retinoids induce apoptosis in breast cancer cells. Our results reveal a new apoptosis paradigm involving translocation of orphan receptor TR3 from the nucleus to the cytoplasm, where it targets mitochondria to induce cytochrome c release and apoptosis. The translocation of TR3 requires its unique heterodimerization with retinoid X receptor (RXRalpha). A putative nuclear export sequence (NES) in RXRalpha mediates nuclear export of TR3/RxRalpha heterodimer. The RXRalpha NES activities are regulated by RXRX dimerization and ligand-binding. In studying how TR3 targets mitochondria, we have discovered that TR3 targets mitochondria through its interaction with Bcl-2. Bcl-2 acts as a mitochondrial receptor of TR3. It mediates the pro-apoptotic effects of TR3 by undergoing a conformational change upon TR3 binding. Such a conformational change converts Bcl-2 from a protector to killer. Together, our studies reveal a novel apoptotic pathway involving TR3, RXRalpha and Bcl-2 in breast cancer cells and our results provide various new strategies for developing agents against breast cancer.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号